市场调查报告书
商品编码
1433342
全球过滤针市场 2023-2030Global Filter Needles Market 2023-2030 |
预计在预测期内(2023-2030年),全球过滤针市场将以7.4%的CAGR成长。老年人口增加、糖尿病盛行率增加、烧伤、道路事故和创伤事件以及手术过程等事故病例增加等关键因素是推动市场的主要因素。
全球过滤针市场根据类型和最终用户进行细分。根据类型,市场分为不銹钢和玻璃。此外,根据最终用户,市场分为医院、诊所和门诊手术中心。在最终用户中,由于门诊手术的显着转变、特定手术的适当专业化、对微创手术的日益关注以及采用技术进步。
在原料中,玻璃细分市场预计将在全球过滤针市场中占据相当大的份额。细分市场的成长归因于玻璃针的几个优点,例如适合高精度工作、低体积误差和成本效率,预计将推动市场发展。玻璃针的这些优点使其适合在类似的医疗技术领域使用。根据美国国立卫生研究院的研究,发表的文章《单剂量安瓿中掺假的玻璃颗粒:患者安全问题》使用过滤针头并倾斜安瓿可以帮助减少进入註射器溶液中的玻璃颗粒数量。
全球过滤针市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于新兴经济体的治疗率上升、可支配收入增加和医疗基础设施改善正在推动亚太地区的过滤针市场,预计亚太地区将在全球市场中占据显着份额。
在所有地区中,北美地区预计在预测期内将以相当大的CAGR成长。由于手术数量增加、对创新过滤针的需求增加以及医疗保健支出增加等因素预计将推动预测期内的市场成长,北美市场正在成长。根据经济合作暨发展组织(OECD)的数据,2021年,美国医疗保健支出占国内生产毛额(GDP)的17.8%,几乎是经合组织国家平均水准的两倍。此外,心血管和神经系统疾病等慢性疾病的盛行率正在快速增长,加速了北美手术持针器市场的发展。美国代谢与减肥外科学会预计,2021 年,2 型糖尿病将成为最常见的糖尿病形式。美国有 3,260 万人患有第 2 型糖尿病。此外,这种疾病导致许多严重的健康问题,包括心臟病、中风、高血压、肾衰竭、失明、皮肤伤口、神经损伤(神经病变)、勃起功能障碍和认知能力下降等。此类疾病需要手术,预计将推动过滤针市场的需求。
服务过滤针市场的主要公司包括 ICU Medical Inc.、MYCO Medical Supplies, Inc.、Novo Nordisk Inc.、Sentra Medical、Sol-Millennium Medical Group、Stryker Corp.、Terumo Corp.、Thermo Fisher Scientific Inc. 和其他的。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2023 年 4 月,CarrTech Corp. 开发了 FROG (R) 过滤针,这是一项改变产业的创新。 FROG (R) 是他们的旗舰产品,代表「过滤去除玻璃」。这种革命性的设备是第一个也是唯一一个将过滤器和皮下注射针组合在一起的一体式包装。苏数十年的专业经验启发了她,她看到了打开玻璃安瓿并从中提取药物的危险。
Global Filter Needles Market Size, Share & Trends Analysis Report by Raw Material (Stainless-Steel and Glass), by End-User (Hospital, Clinics, and Ambulatory Surgery Centers), Forecast Period (2023-2030)
The global filter needles market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). Pivotal factors such as the increasing geriatric population, increasing prevalence of diabetes, the increasing cases of accidents such as burns, road accidents and trauma incidences and surgical processes are some of the major factors driving the market.
The global filter needles market is segmented based on the type, and end-user. Based on the type, the market is sub-segmented into stainless steel and glass. Further, based on end user, the market is sub-segmented into hospital, clinics, and ambulatory surgery centers. Among the end user, the ambulatory surgical centers sub-segment is anticipated to hold a considerable share of the market, owing to the significant shift toward outpatient procedures, proper specialization in specific procedures, the rising focus on minimally invasive procedures, and the adoption of technological advancements.
Among the raw material, the glass sub-segment is expected to hold a considerable share of the global filter needles market. Segmental growth is attributed to several advantages of glass needles, such as suitability for high precision work, low volume error, and cost efficiency, are projected to drive the market. These advantages of glass needles make them appropriate for use in fields comparable medical technology. According to the National Institutes of Health study, article published Glass particulate adulterated in single dose ampoules: A patient safety concern, using filtered needles and leaning the ampoules can help reduce the number of glass particulates that pass into the solutions being drawn into the syringes.
The global filter needles market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising treatment rates, the rising disposable income and improving healthcare infrastructure in emerging economies are driving the filter needles market in the Asia-Pacific.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to factors including the rising number of surgeries, increasing demand for innovative filter needles, and rising healthcare expenditure are projected to drive market growth over the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Further, rising prevalence of chronic diseases, such as cardiovascular and neurological disorders is growing at a rapid pace thus accelerating the surgical needle holder market in North America. American Society for Metabolic and Bariatric Surgery, in 2021, type 2 diabetes, the most common form of diabetes. There are 32.6 million people in the US living with type 2 diabetes. Moreover, this disease led to many serious health problems including heart disease, stroke, high blood pressure, kidney failure, blindness, skin wounds, nerve damage (neuropathy), erectile dysfunction, and cognitive decline among many others. Such diseases required to the surgery which anticipate propelling the demand for filter needles market.
The major companies serving the filter needles market include ICU Medical Inc., MYCO Medical Supplies, Inc., Novo Nordisk Inc., Sentra Medical, Sol-Millennium Medical Group, Stryker Corp., Terumo Corp., Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, CarrTech Corp. developed FROG® filter needle, an industry-altering innovation. FROG®, their flagship product, stands for "filter removal of glass." This revolutionary device is the first and only all-in-one package filter and hypodermic needle combined. Sue was inspired by decades of professional experience, seeing the dangers associated with opening and extracting medicines from glass ampoules.